학술논문

OVARIO, A Phase 2 Study of Niraparib plus Bevacizumab in Advanced Ovarian Cancer (OC) Following Front-Line Platinum-Based Chemotherapy (CT) with Bevacizumab (bev): Updated Analysis
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; NOV 2022, 45 SUPPL 3, p113-p113, 1p. Supplement: 3
Subject
Language
English
ISSN
22965262